These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6514386)
1. Binding capacity of sera from systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) to C3c. Evaluation by enzyme linked immunosorbent assay (ELISA). Bringuier JP; Veysseyre CM; Martin C; Raffin T; Monier JC Pathol Biol (Paris); 1984 Dec; 32(10):1029-32. PubMed ID: 6514386 [TBL] [Abstract][Full Text] [Related]
2. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K; Hoch S; Dima C; Varga J; Teodorescu M J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030 [TBL] [Abstract][Full Text] [Related]
3. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA. Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806 [TBL] [Abstract][Full Text] [Related]
4. A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. Durand CG; Burge JJ J Immunol Methods; 1984 Oct; 73(1):57-66. PubMed ID: 6491304 [TBL] [Abstract][Full Text] [Related]
5. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis. Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766 [TBL] [Abstract][Full Text] [Related]
7. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA. Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Khan F; Siddiqui AA Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series. Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967 [TBL] [Abstract][Full Text] [Related]
10. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422 [TBL] [Abstract][Full Text] [Related]
11. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442 [TBL] [Abstract][Full Text] [Related]
12. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
13. [Anti-fibronectin autoantibodies in systemic lupus erythematosus, rheumatoid polyarthritis, and various viral or bacterial infectious diseases]. Henane T; Rigal D; Monier JC Pathol Biol (Paris); 1986 Mar; 34(3):165-71. PubMed ID: 3517785 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis. Costa O; Pinatel K; Monier JC J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204 [TBL] [Abstract][Full Text] [Related]
15. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. Costa O; Monier JC J Rheumatol; 1986 Aug; 13(4):722-5. PubMed ID: 3772919 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis. Cook AD; Rowley MJ; Wines BD; Mackay IR J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456 [TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus. Rosenau BJ; Schur PH J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453 [TBL] [Abstract][Full Text] [Related]